About
RareCan provides tumour genomic analysis, genetic testing, and personalised clinical trial navigation to support people with rare or less common cancers in the UK, including operating a patient BioResource for research and trial matching.
Explore RareCan's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.